European Journal of Dermatology
MENUEditorial: What's new this month? Volume 27, issue 2, March-April 2017
Authors
1 Department of Dermatology,
Venerology and Allergology,
University Hospital Wuerzburg,
Joseph-Schneider-Str. 2,
97080 Wuerzburg,
Germany
Venerology and Allergology,
University Hospital Wuerzburg,
Joseph-Schneider-Str. 2,
97080 Wuerzburg,
Germany
4 Dermatology Department,
Hospital de Santo António dos Capuchos -Centro Hospitalar de Lisboa Central,
Lisboa,
Portugal
Hospital de Santo António dos Capuchos -Centro Hospitalar de Lisboa Central,
Lisboa,
Portugal
6 Department of Dermatology and Venereology,
Hôpital de Beaumont,
Lausanne University Hospital Center,
Av. de Beaumont 29,
CH-1011 Lausanne,
Switzerland
Hôpital de Beaumont,
Lausanne University Hospital Center,
Av. de Beaumont 29,
CH-1011 Lausanne,
Switzerland
- DOI : 10.1684/ejd.2017.3000
- Page(s) : 214-5
- Published in: 2017
Isothiazolinone derivatives, such as methylisothiazolinone (MI), methylchloroisothiazolinone (MCI), benzisothiazolinone (BIT), and octylisothiazolinone (OIT), are widely used as preservatives in a large variety of products due to their strong bactericide, fungicide, and algicide properties [1]. However, for consumers and workers in various industries, these chemicals represent a significant source of allergic contact dermatitis. Previous reports have found that up to 9% of all patients referred for [...]